Physician profile
Pardeep Kaur
NPI 1225783855
$2,197.44
in general payments reported to CMS, 2019-2025
18 companies · $421 in 2025
The $421 reported for 2025 was more than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $1,114 · 2023: $314 · 2024: $348 · 2025: $421.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,026 · Travel and Lodging: $39.99 · Education: $18.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,025.79 |
| Travel and Lodging | $39.99 |
| Education | $18.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $1,121.91 | 2022-2025 | General - Therapies, Accolade Sr, Lux-Dx Insertable Cardiac Monitor |
| Novartis Pharmaceuticals Corporation | $430.30 | 2022-2025 | |
| Medtronic, INC. | $205.01 | 2023-2025 | Linq II, Micra, Aurora Ev-Icd Mri Surescan |
| Merck Sharp & Dohme LLC | $102.06 | 2022-2024 | Verquvo |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $48.52 | 2022-2023 | Lifevest |
| E.R. Squibb & Sons, L.L.C. | $38.90 | 2022-2025 | Eliquis |
| Boehringer Ingelheim Pharmaceuticals, INC. | $38.12 | 2022-2023 | Jardiance |
| Actelion Pharmaceuticals US, INC. | $29.92 | 2025 | Uptravi, Opsynvi |
| Lilly USA, LLC | $25.54 | 2025 | Mounjaro |
| Convatec INC. | $22.92 | 2025 | |
| Kestra Medical Technology Services, INC. | $20.90 | 2024 | Assure Wcd |
| Pfizer INC. | $19.67 | 2024 | |
| Ionis Pharmaceuticals, INC. | $17.96 | 2025 | Tryngolza |
| Astrazeneca Pharmaceuticals LP | $17.09 | 2023 | Andexxa |
| Heron Therapeutics, INC. | $16.89 | 2024 | Zynrelef |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Philips North America LLC | $14.36 | 2024 | (Ck4) Mcot |
| Kiniksa Pharmaceuticals, LTD. | $13.69 | 2022 | |
| Amgen INC. | $13.68 | 2025 | Repatha |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Pardeep Kaur listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.